Before you start
- Usually prescribed at a BMI of 30 or more, or 27 or more with a weight-related condition. A clinician decides.
- Not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or who is pregnant.
- Take birth control pills? The FDA-approved tirzepatide label says to switch to a non-pill method or add a barrier method for 4 weeks after you start and after each dose increase.
- On hormone therapy, or in perimenopause or menopause? Tell your clinician so they see the full picture.











